Real World Data and its Healthcare Applications Report

The Real World Data Report is a crucial up-to-date, independent and strategic insight into the most cutting edge
real world data practices. The report extract, with contributions from GSK, NovoNordisk, Pfizer, Sanofi, Janssen,
BMS and Amgen as well the AHRQ shares data sources they use and how they deal with issues such as data gaps, non-
standardization and retrospective study data.

You might also be interested in:

23andME CEO Talks Privacy, Deal with GSK September 11, 2018
Janssen Releases 2017 Transparency Report March 22, 2018
Abarca, Amgen OK Outcomes-Based Deal for Repatha February 23, 2018
Amgen to Use BC Platforms’ Data Solutions in… January 10, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
U.K.’s NICE Backs Janssen Cancer Drug January 18, 2018
New Data, Research Methods Provide Better Insight into Patient… May 28, 2018